天然产物抗癌研究进展
|
摘要
恶性肿瘤是现代社会威胁人类健康的重要杀手。合理有效的药物应用为恶性肿瘤治疗提供了有效手段,并有望成为未来解决肿瘤治疗难题的重要途径。近年来,随着肿瘤新理论的不断升级,以及肿瘤耐药等临床用药问题的不断涌现,创新的抗癌药物研发始终是肿瘤研究的热点和重点。其中,天然产物以其明确的抗癌有效性、候选资源的丰富性等优势,成为抗癌药物研发的重中之重。因此,在抗癌天然产物研究"热、多、杂"的背景下,条理化地归纳天然产物抗癌的进展,总结梳理其合理靶点及潜在机制,并在此基础上提示出未来进一步抗癌天然产物发展的新方向和新动态,是势在必行的。文章以肿瘤疾病进展的全链条为串联思路,以抗癌天然活性成分靶点的特征为切入点,着重从传统应用和创新应用两方面,对目前天然产物抗癌的研究进展进行总述。希望能够较为全面地揭示出天然产物抗癌的发展路径,并为抗癌药物的创新研发提供启示和思路。
Human health has been severely threatened by malignant tumors continuously.Rational and effective drug use provides an effective means for the treatment of malignant tumors,and is expected to become an important way to solve the problem of tumor treatment in the future.In recent years,with the escalation of new cancer theories and the emergence of clinical drug resistance,innovative research and development of anti-cancer drugs has always been a hot spot and focus in cancer research.Among them,the discovery of novel anti-cancer drugs from natural compound is of top priority due to its strong anti-cancer efficacy and the abundant drug resources.Therefore,it is imperative to systematically summarize the cutting-edge advancements of the natural products and their potential pharmacological mechanisms according to the characteristics of tumor progression,and put forward the new directions and trends for further development of anti-cancer natural products in the future.Specifically,the research advancements on anti-cancer effect of natural products were reviewed,focusing on both the traditional and innovative application.We hope this review could bring the light on the research path of the natural anti-cancer products clearly and comprehensively,and also provide inspirations for innovative,safer and more effective anti-cancer drug development and exploration.
Human health has been severely threatened by malignant tumors continuously.Rational and effective drug use provides an effective means for the treatment of malignant tumors,and is expected to become an important way to solve the problem of tumor treatment in the future.In recent years,with the escalation of new cancer theories and the emergence of clinical drug resistance,innovative research and development of anti-cancer drugs has always been a hot spot and focus in cancer research.Among them,the discovery of novel anti-cancer drugs from natural compound is of top priority due to its strong anti-cancer efficacy and the abundant drug resources.Therefore,it is imperative to systematically summarize the cutting-edge advancements of the natural products and their potential pharmacological mechanisms according to the characteristics of tumor progression,and put forward the new directions and trends for further development of anti-cancer natural products in the future.Specifically,the research advancements on anti-cancer effect of natural products were reviewed,focusing on both the traditional and innovative application.We hope this review could bring the light on the research path of the natural anti-cancer products clearly and comprehensively,and also provide inspirations for innovative,safer and more effective anti-cancer drug development and exploration.
引文
[1]Hanahan D,Weinberg R A,Hallmarks of cancer:the next generation[J].Cell,2011,144:646.
[2]Bayona-Bafaluy M P,López-Gallardo E,Montoya J,et al.Maternally inherited susceptibility to cancer[J].Biochim Biophys Acta,2011,1807(6):643.
[3]杨楠,贾晓斌,张振海,等.黄酮类化合物抗肿瘤活性及机制研究进展[J].中国中药杂志,2015,40(3):373.
[4]Kou Y,Cheun Y,Koag.M.C,et al.Synthesis of 14',15'-dehydro-ritterazine Y via reductive and oxidative functionalizations of hecogenin acetate[J].Steroids,2013,78:304.
[5]苏新堯,薛建平,王彩霞.中药功效成分合成生物学研究进展[J].中国中药杂志,2016,41(22):4150.
[6]Huang T,Xiao Y,Yi L,et al.Coptisine from Rhizoma Coptidis suppresses HCT-116 cells-related tumor growth in vitro and in vivo[J].Sci Rep,2017,2(7):38524.
[7]Lei X,Kou Y,Fu Y,et al.The cancer mutation D83V induces anα-helix toβ-strand conformation switch in MEF2B[J].Mol Biol,2018,430(8):1157.
[8]Jedhe G S,Paul D,Gonnade R G,et al.Correlation of hydrogen-bonding propensity and anticancer profile of tetrazole-tethered combretastatin analogues[J].Bioorg Med Chem Lett,2013,23(4):4680.
[9]von Pawel J,Gorbounova V,Reck M,et al.DISRUPT:a randomised phase 2 trial of ombrabulin(AVE8062)plus a taxaneplatinum regimen as first-line therapy for metastatic non-small cell lung cancer[J].Lung Cancer,2014,85(2):224.
[10]Mita M M,Spear M A,Yee L K,et al.Phase 1 first-in-human trial of the vascular disrupting agent plinabulin(NPI-2358)in patients with solid tumors or lymphomas[J].Clin Cancer Res,2010,16(23):5892.
[11]Morgensztern D,Herbst R S.Lung cancer,an issue of hematology/oncology clinics[M].Amsterdam:Elsevier,2016.
[12]Hayashi Y,Yamazaki-Nakamura Y,Yakushiji F,et al.Medicinal chemistry and chemical biology of diketopiperazine-type antimicrotubule and vascular-disrupting agents[J].Chem Pharm Bull(Tokyo),2013,61(9):889.
[13]Cabrera-Galeana P,Mu1oz-Monta1o W,Lara-Medina F,et al.Ki67changes identify worse outcomes in residual breast cancer tumors after neoadjuvant chemotherapy[J].Oncologist,2018,23(6):670.
[14]Sculier J P,Lafitte J J,Berghmans T,et al.A phaseⅢrandomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer[J].Lung Cancer,2018,117:32.
[15]Kumar A,Wakelee H,et al.Second-and third-line treatments in non-small cell lung cancer[J].Curr Treat Options Oncol,2006,7:37.
[16]Kumara P M,Soujanya K N,Ravikanth G,et al.Rohitukine,a chromone alkaloid and a precursor of flavopiridol,is produced by endophytic fungi isolated from Dysoxylum binectariferum Hook.f and Amoora rohituka(Roxb).Wight&Arn[J].Phytomedicine,2014,15(21):541.
[17]Cihalova D,Staud F,Ceckova M,et al.Interactions of cyclindependent kinase inhibitors AT-7519,flavopiridol and SNS-032with ABCB1,ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro[J].Cancer Chemother Pharmacol,2015,76:105.
[18]Joshi S,Singh A R,Durden D L,et al.Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma[J].Cancer Chemother Pharmacol,2015,75:595.
[19]Farahi N,Uller L,Juss J K,et al.Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance[J].Clin Exp Allergy,2011,41(5):673.
[20]Yoo L,Chung K C,et al.The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death[J].J Biol Chem,2018,293(4):1286.
[21]Saleem R S Z,Tepe J J,et al.A concise total synthesis of hymenialdisine[J].Tetrahedron Lett,2015,56:3011.
[22]Yang Y,Chen L,Pan H Z,et al.Glycosylation modification of human prion protein provokes apoptosis in He La cells in vitro[J].BMB Rep,2009,42(6):331.
[23]Shakeri A,Ward N,Panahi Y,et al.Sahebkar,anti-angiogenic activity of curcumin in cancer therapy:a narrative review[J].Curr Vasc Pharmacol,2018,doi:10.2174/1570161116666180209113014.
[24]Kim C E,Jun D Y,Kim J S,et al.Cis-trimethoxy resveratrol induces intrinsic apoptosis via prometaphase arrest and prolonged CDK1 activation pathway in human Jurkat T cells[J].Oncotarget,2017,9(4):4969.
[25]Farooqi A A,Khalid S,Ahmad A,et al.Regulation of cell signaling pathways and miRNAs by resveratrol in different cancers[J].Int J Mol Sci,2018,19(3);652.
[26]George A,Raji I,Cinar B,et al.Design,synthesis,and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates[J].Bioorg Med Chem,2018,26(8):1481.
[27]Safarzadeh E,Sandoghchian Shotorbani S,Baradaran B,et al.Herbal medicine as inducers of apoptosis in cancer treatment[J].Adv Pharm Bull,2014,4(Suppl 1):421.
[28]Fernandez-Herrera M A,Lopez-Munoz H,Hernandez-Vazquez JM,et al.Synthesis of 26-hydroxy-22-oxocholestanic frameworks from diosgenin and hecogenin and their in vitro antiproliferative and apoptotic activity on human cervical cancer CaSki cells[J].Bioorg Med Chem,2010,18(7):2474.
[29]Cheun Y,Kou Y,Stevenson B,et al.Synthesis of C17-OH-north unit of ritterazine G via"Red-Ox"modifications of hecogenin acetate[J].Steroids,2013,78(7):639.
[30]Tee T T,Cheah Y H,Meenakshii N,et al.Xanthorrhizol induced DNA fragmentation in Hep G2 cells involving Bcl-2 family proteins[J].Biochem Biophys Res Commun,2012,420(4):834.
[31]Kim J Y,An J M,Chung W Y,et al.Xanthorrhizol induces apoptosis through ROS-mediated MAPK activation in human oral squamous cell carcinoma cells and inhibits DMBA-induced oral carcinogenesis in hamsters[J].Phytother Res,2013,27(4):493.
[32]Brownell J,Polyak S J,et al.Molecular pathways:hepatitis C virus,CXCL10,and the inflammatory road to liver cancer[J].Clin Cancer Res,2013,19(6):1347.
[33]Wang F,Meng W,Wang B,et al.Helicobacter pylori-induced gastric inflammation and gastric cancer[J].Cancer Lett,2014,345(2):196.
[34]Terzic J,Grivennikov S,Karin E,et al.Inflammation and colon cancer[J].Gastroenterology,2010,138:2101.
[35]Tanabe K,Matsushima-Nishiwaki R,Yamaguchi S,et al.Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells[J].J Neuroinflammation,2010,7:16.
[36]Liu Y Q,Hong Z L,Zhan L B,et al.Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway[J].Sci Rep,2016,6:32260.
[37]Bahabadi M,Mohammadalipour A,Karimi J,et al.Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease[J].Immunopharmacol Immunotoxicol,2017,39(4):233.
[38]Mohan V,Agarwal R,Singh R P,et al.A novel alkaloid,evodiamine causes nuclear localization of cytochrome-c and induces apoptosis independent of p53 in human lung cancer cells[J].Biochem Biophys Res Commun,2016,477(4):1065.
[39]陆惠平,马芬芬,龚婧如,等.冬凌草甲素联合卡培他滨对人乳腺癌MDA-MB-231细胞增殖的影响[J].中华医学杂志,2017,97(46):3647.
[40]Woo S M,Kwon T K.Jaceosidin induces apoptosis through Bax activation and down-regulation of Mcl-1 and c-FLIP expression in human renal carcinoma Caki cells[J].Chem Biol Interact,2016,260:168.
[41]Han H S,Jang E,Shin J S,et al.Kyungheechunggan-Tang-01,a new herbal medication,suppresses LPS-induced inflammatory responses through JAK/STAT signaling pathway in RAW 264.7macrophages[J].Evid Based Complement Alternat Med,2017,2017:7383104.
[42]Furqan M.STAT inhibitors for cancer therapy[J].J Hematol Oncol,2013,5(6):90.
[43]Lim H S,Jin S E,Kim O S,et al.Alantolactone from Saussurea lappa exerts antiinflammatory effects by inhibiting chemokine production and STAT1 phosphorylation in TNF-αand IFN-γ-induced in Ha CaT cells[J].Phytother Res,2015,29:1088.
[44]Kim J K,Kim J Y,Kim H J,et al.Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity[J].PLoS ONE,2013,8(11):e80391.
[45]Qin J,Wang W,Zhang R.Novel natural product therapeutics targeting both inflammation and cancer[J].Chin J Nat Med,2017,15:401.
[46]Yang Y,Kim S C,Yu T,et al.Functional roles of p38 mitogenactivated protein kinase in macrophage-mediated inflammatory responses[J].Mediators Inflamm,2014(2014):352371.
[47]Lee D C W,Lau A S Y.Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation:a mini-review[J].Molecules,2011,16:2802.
[48]Abdulhameed S,Pradeep N S,Sugathan S.Bioresources and bioprocess in biotechnology[M].Berlin:Springer,2017.
[49]Farooqui T,Farooqui A A.Neuroprotective effects of phytochemicals in neurological disorders[M].New York:John Wiley&Sons,2017.
[50]Sun B,Lin Y,Wang X,et al.Single nucleotide polymorphism of the enhancer of zeste homolog 2 Gene rs2072408 is associated with lymph node metastasis and depth of primary tumor invasion in gastric cancer[J].Clin Lab,2016,62(11):2099.
[51]Liang Y,Xu X,Yu H,et al.Raddeanoside R13 inhibits breast cancer cell proliferation,invasion,and metastasis[J].Tumour Biol,2016,37:9837.
[52]Zhang X,Li Y,Zhang Y,et al.Beta-elemene blocks epithelialmesenchymal transition in human breast cancer cell line MCF-7through Smad3-mediated down-regulation of nuclear transcription factors[J].PLoS ONE,2013,8:e58719.
[53]Wan X Y,Zhai X F,Jiang Y P,et al.Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression[J].Am J Transl Res,2017,9:155.
[54]叶琨,郑娅莉,彭小梅.去甲斑蝥素的药理作用机制及其在肾脏病领域中的应用前景研究进展[J].中国临床新医学,2015,8(9):880.
[55]Yang J,Wang C,Zhang Z,et al.Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway[J].APMIS,2017,125(2):134.
[56]Rahman F U,Ali A,Khan I U,et al.Novel phenylenediamine bridged mixed ligands dimetallic square planner Pt(Ⅱ)complex inhibits MMPs expression via p53 and caspase-dependent signaling and suppress cancer metastasis and invasion[J].Eur J Med Chem,2017,125(1):1064.
[57]Bae M J,Karadeniz F,Oh J H,et al.MMP-inhibitory effects of flavonoid glycosides from edible medicinal halophyte Limonium tetragonum[J].Evid Based Complement Alternat Med,2017(2017):6750274.
[58]Jang S Y,Lee J K,Jang E H,et al.Shikonin blocks migration and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation[J].Oncol Rep,2014,31:2827.
[59]Yang J,Wang C,Zhang Z,et al.Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway[J].APMIS,2017,125(2):134.
[60]Li Q,Kan X,Yin J,et al.Chamaejasmine B induces the anergy of vascular endothelial cells to VEGFA Pro-angiogenic signal by autophagic regulation of VEGFR2 in breast cancer[J].Front Pharmacol,2017,8:963.
[61]Kumar S,Guru S K,Pathania A S,et al.Autophagy triggered by magnolol derivative negatively regulates angiogenesis[J].Cell Death Dis,2013,4:e889.
[62]Chen S,Liu W,Wang K,et al.Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-kappaB/MMP-9 signaling[J].PLoS ONE,2017,12(3):725.
[63]Rich J N.Cancer stem cells:understanding tumor hierarchy and heterogeneity[J].Medicine(Baltimore),2016,95(1Suppl 1):2.
[64]Dean M,Fojo T,Bates S.Tumor stem cells and drug resistance[J].Nat Rev Cancer,2005,5(4):275.
[65]Kim J,Lee J S,Jung J,et al.Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variantⅢin glioma stem cells[J].Stem Cells Dev,2014,24(3):284.
[66]卢小路,徐海波,石梦莹,等.半枝莲通过Hedgehog信号通路抑制结肠肿瘤干细胞自我更新[J].中药药理与临床,2015,31(1):139.
[67]张英.苦参提取物对人乳腺癌MCF-7细胞系肿瘤干细胞样细胞生物学行为的干预研究[D].北京:中国中医科学院,2009.
[68]Witt O,Deubzer H E,Milde T,et al.HDAC family:What are the cancer relevant targets?[J].Cancer Lett,2009,277:8.
[69]刘裕婷.新型去乙酰化酶抑制剂厚朴酚激活TRAIL通路诱导NSCLC凋亡的机制研究[D].广州:南方医科大学,2016.
[70]黎欢.艾可清2号组方及其他中药来源单体HDAC抑制活性研究[D].广州:广州中医药大学,2017.
[71]Yoon S,Eom G H.HDAC and HDAC inhibitor:from cancer to cardiovascular diseases[J].Chonnam Med J,2016,52:1.
[72]Battistuzzi G,Giannini G.Synthesis of ST7612AA1,a novel oral HDAC inhibitor,via radical thioacetic acid addition[J].Curr Bioact Compd,2016,12:282.
[73]Gorska M,Popowska U,Sielicka-Dudzin A,et al.Geldanamycin and its derivatives as Hsp90 inhibitors[J].Front Biosci,2012,1(17):2269.
[74]Wang J,Li Z,Lin Z,et al.17-DMCHAG,a new geldanamycin derivative,inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation[J].Cancer Lett,2015,362(1):83.
[75]Palermo C M,Westlake C A,Gasiewicz T A,et al.Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 k D heat shock protein[J].Biochemistry,2005,44:5041.
[76]Willem H K,Patricia L B,Chi V D.Otto Warburg's contributions tocurrent concepts of cancer metabolism[J].Nat Rev Cancer,2011,11:325.
[77]Li S,Li J,Dai W,et al.Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death[J].Br J Cancer,2017,117(10):1518.
[78]Hattori H,Okuda K,Murase T,et al.Isolation,identification and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis[J].Bioorg Med Chem,2011,19(18):5392.
[79]Ansell S M,Vonderheide R H.Cellular composition of the tumor microenvironment.American Society of Clinical Oncology educational book[J].Am Soc Clin Oncol Educ Book,2013,doi:10.1200/EdBook_AM.2013.33.e91.
[80]楼姣英,曹颖,金哲.中药对SiHa-CTL-Treg共培养体系中CTL细胞CTLA-4、PD-1蛋白的影响[J].北京中医药大学学报,2014,37(4):227.
[81]Vetizou M,Pitt J M,Daillere R,Lepage P,et al.Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota[J].Science,2015,350:1079.
[82]Stojanovic A,Cerwenka A.Naturalkiller cells and solid tumors[J].J Innate Immun,2011,3(4):355.
[83]宋浩然,白咸勇.红花组分抗肿瘤作用机制研究进展[J].中国民康医学,2016,28(24):43.
[84]林俊,李萍,陈靠山.近5年多糖抗肿瘤活性研究进展[J].中国中药杂志,2013,38(8):1116.
[85]Wang J M,Hu Y L,Wang D Y,et al.Sulfated modification can enhance the immune-enhancing activity of lycium barbarum polysaccharide[J].Cell Immunol,2010,263(2):219.
[86]李子豪,柯仲成,封亮,等.宝藿苷Ⅰ的制备方法及药理作用研究进展[J].中国中药杂志,2018,43(17):3444.
[87]Finnberg N,Klein-Szanto A J,El-Deiry W S.TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis[J].J Clin Invest,2008,118(1):111.
[88]Chen Z,Sangwan V,Banerjee S,et al.Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway[J].Cancer Lett,2014,348:1.
[89]Yong-Sik K,Eun-Ae K,Kyu-Gun P,et al.Dioscin sensitizes cells to TRAIL-induced apoptosis through downregulationof c-FLIP and Bcl-2[J].Oncol Rep,2012,28:5.
[90]Kou Y,Koag M C,Cheun Y,et al.Application of hypoioditemediated aminyl radical cyclization to synthesis of solasodine acetate[J].Steroids,2012,77:1069.
[91]Dai X,Zhang J,Arfuso F,et al.Targeting TNF-related apoptosis-inducing ligand(TRAIL)receptor by natural products as a potential therapeutic approach for cancer therapy[J].Exp Biol Med,2015,240(6):760.
[92]闫忠辉,李小平,刘煜.海洋植物来源的天然产物的研究进展[J].药物生物技术,2017,24(3):269.
[93]Brown A P,Morrissey R L,Faircloth G T,et al.Preclinical toxicity studies of kahalalide F,a new anticancer agent:single and muitiple dosing regiments in the rat[J].Canc Chem Pharmacol,2002,50(4):333.
[94]Linington R G,Edwards D J,Shuman C F,et al.Symplocamide A,a potent cytotoxin and chymotrypsin inhibitor from the marine cyanobacterium Symploca sp[J].J Nat Prod,2008,71:22.
[95]Kou Y,Lee S.Unexpected opening of steroidal E-ring during hypoiodite-mediated oxidation[J].Tetrahedron Lett,2013,54:4106.
[96]Cheun Y,Koag M C,Kou Y,et al.Transetherification-mediated E-ring opening and stereoselective"Red-Ox"modification of furostan[J].Steroids,2012,77:276.
[97]Koag M C,Cheun Y,Kou Y,et al.Synthesis and structure of16,22-diketocholesterol bound to oxysterol-binding protein Osh4[J].Steroids,2013,78:938.
[98]Perni M,Galvagnion C,Maltsev A,et al.A natural product inhibits the initiation ofα-synuclein aggregation and suppresses its toxicity[J].Proc Natl Acad Sci USA,2017,114:E1009.
[99]Wroblewski J J,Hu A Y.Topical squalamine 0.2%and intravitreal ranibizumab 0.5 mg as combination therapy for macular edema due to branch and central retinal vein occlusion:an open-label,randomized study[J].Ophthalmic Surg Lasers Imaging Retina,2016,47:914.
[100]Siegel R L,Miller K D,Jemal A.Cancer statistics,2018[J].CACancer J Clin,2018,68(1):7.
[101]Allemani C,Matsuda T,Di Carlo V,et al.Global surveillance of trends in cancer survival 2000-14(CONCORD-3):analysis of individual records for 37 513 025 patients diagnosed with one of18 cancers from 322 populationbased registries in 71 countries[J].Lancet,2018,391:1023.
[2]Bayona-Bafaluy M P,López-Gallardo E,Montoya J,et al.Maternally inherited susceptibility to cancer[J].Biochim Biophys Acta,2011,1807(6):643.
[3]杨楠,贾晓斌,张振海,等.黄酮类化合物抗肿瘤活性及机制研究进展[J].中国中药杂志,2015,40(3):373.
[4]Kou Y,Cheun Y,Koag.M.C,et al.Synthesis of 14',15'-dehydro-ritterazine Y via reductive and oxidative functionalizations of hecogenin acetate[J].Steroids,2013,78:304.
[5]苏新堯,薛建平,王彩霞.中药功效成分合成生物学研究进展[J].中国中药杂志,2016,41(22):4150.
[6]Huang T,Xiao Y,Yi L,et al.Coptisine from Rhizoma Coptidis suppresses HCT-116 cells-related tumor growth in vitro and in vivo[J].Sci Rep,2017,2(7):38524.
[7]Lei X,Kou Y,Fu Y,et al.The cancer mutation D83V induces anα-helix toβ-strand conformation switch in MEF2B[J].Mol Biol,2018,430(8):1157.
[8]Jedhe G S,Paul D,Gonnade R G,et al.Correlation of hydrogen-bonding propensity and anticancer profile of tetrazole-tethered combretastatin analogues[J].Bioorg Med Chem Lett,2013,23(4):4680.
[9]von Pawel J,Gorbounova V,Reck M,et al.DISRUPT:a randomised phase 2 trial of ombrabulin(AVE8062)plus a taxaneplatinum regimen as first-line therapy for metastatic non-small cell lung cancer[J].Lung Cancer,2014,85(2):224.
[10]Mita M M,Spear M A,Yee L K,et al.Phase 1 first-in-human trial of the vascular disrupting agent plinabulin(NPI-2358)in patients with solid tumors or lymphomas[J].Clin Cancer Res,2010,16(23):5892.
[11]Morgensztern D,Herbst R S.Lung cancer,an issue of hematology/oncology clinics[M].Amsterdam:Elsevier,2016.
[12]Hayashi Y,Yamazaki-Nakamura Y,Yakushiji F,et al.Medicinal chemistry and chemical biology of diketopiperazine-type antimicrotubule and vascular-disrupting agents[J].Chem Pharm Bull(Tokyo),2013,61(9):889.
[13]Cabrera-Galeana P,Mu1oz-Monta1o W,Lara-Medina F,et al.Ki67changes identify worse outcomes in residual breast cancer tumors after neoadjuvant chemotherapy[J].Oncologist,2018,23(6):670.
[14]Sculier J P,Lafitte J J,Berghmans T,et al.A phaseⅢrandomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer[J].Lung Cancer,2018,117:32.
[15]Kumar A,Wakelee H,et al.Second-and third-line treatments in non-small cell lung cancer[J].Curr Treat Options Oncol,2006,7:37.
[16]Kumara P M,Soujanya K N,Ravikanth G,et al.Rohitukine,a chromone alkaloid and a precursor of flavopiridol,is produced by endophytic fungi isolated from Dysoxylum binectariferum Hook.f and Amoora rohituka(Roxb).Wight&Arn[J].Phytomedicine,2014,15(21):541.
[17]Cihalova D,Staud F,Ceckova M,et al.Interactions of cyclindependent kinase inhibitors AT-7519,flavopiridol and SNS-032with ABCB1,ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro[J].Cancer Chemother Pharmacol,2015,76:105.
[18]Joshi S,Singh A R,Durden D L,et al.Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma[J].Cancer Chemother Pharmacol,2015,75:595.
[19]Farahi N,Uller L,Juss J K,et al.Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance[J].Clin Exp Allergy,2011,41(5):673.
[20]Yoo L,Chung K C,et al.The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death[J].J Biol Chem,2018,293(4):1286.
[21]Saleem R S Z,Tepe J J,et al.A concise total synthesis of hymenialdisine[J].Tetrahedron Lett,2015,56:3011.
[22]Yang Y,Chen L,Pan H Z,et al.Glycosylation modification of human prion protein provokes apoptosis in He La cells in vitro[J].BMB Rep,2009,42(6):331.
[23]Shakeri A,Ward N,Panahi Y,et al.Sahebkar,anti-angiogenic activity of curcumin in cancer therapy:a narrative review[J].Curr Vasc Pharmacol,2018,doi:10.2174/1570161116666180209113014.
[24]Kim C E,Jun D Y,Kim J S,et al.Cis-trimethoxy resveratrol induces intrinsic apoptosis via prometaphase arrest and prolonged CDK1 activation pathway in human Jurkat T cells[J].Oncotarget,2017,9(4):4969.
[25]Farooqi A A,Khalid S,Ahmad A,et al.Regulation of cell signaling pathways and miRNAs by resveratrol in different cancers[J].Int J Mol Sci,2018,19(3);652.
[26]George A,Raji I,Cinar B,et al.Design,synthesis,and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates[J].Bioorg Med Chem,2018,26(8):1481.
[27]Safarzadeh E,Sandoghchian Shotorbani S,Baradaran B,et al.Herbal medicine as inducers of apoptosis in cancer treatment[J].Adv Pharm Bull,2014,4(Suppl 1):421.
[28]Fernandez-Herrera M A,Lopez-Munoz H,Hernandez-Vazquez JM,et al.Synthesis of 26-hydroxy-22-oxocholestanic frameworks from diosgenin and hecogenin and their in vitro antiproliferative and apoptotic activity on human cervical cancer CaSki cells[J].Bioorg Med Chem,2010,18(7):2474.
[29]Cheun Y,Kou Y,Stevenson B,et al.Synthesis of C17-OH-north unit of ritterazine G via"Red-Ox"modifications of hecogenin acetate[J].Steroids,2013,78(7):639.
[30]Tee T T,Cheah Y H,Meenakshii N,et al.Xanthorrhizol induced DNA fragmentation in Hep G2 cells involving Bcl-2 family proteins[J].Biochem Biophys Res Commun,2012,420(4):834.
[31]Kim J Y,An J M,Chung W Y,et al.Xanthorrhizol induces apoptosis through ROS-mediated MAPK activation in human oral squamous cell carcinoma cells and inhibits DMBA-induced oral carcinogenesis in hamsters[J].Phytother Res,2013,27(4):493.
[32]Brownell J,Polyak S J,et al.Molecular pathways:hepatitis C virus,CXCL10,and the inflammatory road to liver cancer[J].Clin Cancer Res,2013,19(6):1347.
[33]Wang F,Meng W,Wang B,et al.Helicobacter pylori-induced gastric inflammation and gastric cancer[J].Cancer Lett,2014,345(2):196.
[34]Terzic J,Grivennikov S,Karin E,et al.Inflammation and colon cancer[J].Gastroenterology,2010,138:2101.
[35]Tanabe K,Matsushima-Nishiwaki R,Yamaguchi S,et al.Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells[J].J Neuroinflammation,2010,7:16.
[36]Liu Y Q,Hong Z L,Zhan L B,et al.Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway[J].Sci Rep,2016,6:32260.
[37]Bahabadi M,Mohammadalipour A,Karimi J,et al.Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease[J].Immunopharmacol Immunotoxicol,2017,39(4):233.
[38]Mohan V,Agarwal R,Singh R P,et al.A novel alkaloid,evodiamine causes nuclear localization of cytochrome-c and induces apoptosis independent of p53 in human lung cancer cells[J].Biochem Biophys Res Commun,2016,477(4):1065.
[39]陆惠平,马芬芬,龚婧如,等.冬凌草甲素联合卡培他滨对人乳腺癌MDA-MB-231细胞增殖的影响[J].中华医学杂志,2017,97(46):3647.
[40]Woo S M,Kwon T K.Jaceosidin induces apoptosis through Bax activation and down-regulation of Mcl-1 and c-FLIP expression in human renal carcinoma Caki cells[J].Chem Biol Interact,2016,260:168.
[41]Han H S,Jang E,Shin J S,et al.Kyungheechunggan-Tang-01,a new herbal medication,suppresses LPS-induced inflammatory responses through JAK/STAT signaling pathway in RAW 264.7macrophages[J].Evid Based Complement Alternat Med,2017,2017:7383104.
[42]Furqan M.STAT inhibitors for cancer therapy[J].J Hematol Oncol,2013,5(6):90.
[43]Lim H S,Jin S E,Kim O S,et al.Alantolactone from Saussurea lappa exerts antiinflammatory effects by inhibiting chemokine production and STAT1 phosphorylation in TNF-αand IFN-γ-induced in Ha CaT cells[J].Phytother Res,2015,29:1088.
[44]Kim J K,Kim J Y,Kim H J,et al.Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity[J].PLoS ONE,2013,8(11):e80391.
[45]Qin J,Wang W,Zhang R.Novel natural product therapeutics targeting both inflammation and cancer[J].Chin J Nat Med,2017,15:401.
[46]Yang Y,Kim S C,Yu T,et al.Functional roles of p38 mitogenactivated protein kinase in macrophage-mediated inflammatory responses[J].Mediators Inflamm,2014(2014):352371.
[47]Lee D C W,Lau A S Y.Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation:a mini-review[J].Molecules,2011,16:2802.
[48]Abdulhameed S,Pradeep N S,Sugathan S.Bioresources and bioprocess in biotechnology[M].Berlin:Springer,2017.
[49]Farooqui T,Farooqui A A.Neuroprotective effects of phytochemicals in neurological disorders[M].New York:John Wiley&Sons,2017.
[50]Sun B,Lin Y,Wang X,et al.Single nucleotide polymorphism of the enhancer of zeste homolog 2 Gene rs2072408 is associated with lymph node metastasis and depth of primary tumor invasion in gastric cancer[J].Clin Lab,2016,62(11):2099.
[51]Liang Y,Xu X,Yu H,et al.Raddeanoside R13 inhibits breast cancer cell proliferation,invasion,and metastasis[J].Tumour Biol,2016,37:9837.
[52]Zhang X,Li Y,Zhang Y,et al.Beta-elemene blocks epithelialmesenchymal transition in human breast cancer cell line MCF-7through Smad3-mediated down-regulation of nuclear transcription factors[J].PLoS ONE,2013,8:e58719.
[53]Wan X Y,Zhai X F,Jiang Y P,et al.Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression[J].Am J Transl Res,2017,9:155.
[54]叶琨,郑娅莉,彭小梅.去甲斑蝥素的药理作用机制及其在肾脏病领域中的应用前景研究进展[J].中国临床新医学,2015,8(9):880.
[55]Yang J,Wang C,Zhang Z,et al.Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway[J].APMIS,2017,125(2):134.
[56]Rahman F U,Ali A,Khan I U,et al.Novel phenylenediamine bridged mixed ligands dimetallic square planner Pt(Ⅱ)complex inhibits MMPs expression via p53 and caspase-dependent signaling and suppress cancer metastasis and invasion[J].Eur J Med Chem,2017,125(1):1064.
[57]Bae M J,Karadeniz F,Oh J H,et al.MMP-inhibitory effects of flavonoid glycosides from edible medicinal halophyte Limonium tetragonum[J].Evid Based Complement Alternat Med,2017(2017):6750274.
[58]Jang S Y,Lee J K,Jang E H,et al.Shikonin blocks migration and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation[J].Oncol Rep,2014,31:2827.
[59]Yang J,Wang C,Zhang Z,et al.Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway[J].APMIS,2017,125(2):134.
[60]Li Q,Kan X,Yin J,et al.Chamaejasmine B induces the anergy of vascular endothelial cells to VEGFA Pro-angiogenic signal by autophagic regulation of VEGFR2 in breast cancer[J].Front Pharmacol,2017,8:963.
[61]Kumar S,Guru S K,Pathania A S,et al.Autophagy triggered by magnolol derivative negatively regulates angiogenesis[J].Cell Death Dis,2013,4:e889.
[62]Chen S,Liu W,Wang K,et al.Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-kappaB/MMP-9 signaling[J].PLoS ONE,2017,12(3):725.
[63]Rich J N.Cancer stem cells:understanding tumor hierarchy and heterogeneity[J].Medicine(Baltimore),2016,95(1Suppl 1):2.
[64]Dean M,Fojo T,Bates S.Tumor stem cells and drug resistance[J].Nat Rev Cancer,2005,5(4):275.
[65]Kim J,Lee J S,Jung J,et al.Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variantⅢin glioma stem cells[J].Stem Cells Dev,2014,24(3):284.
[66]卢小路,徐海波,石梦莹,等.半枝莲通过Hedgehog信号通路抑制结肠肿瘤干细胞自我更新[J].中药药理与临床,2015,31(1):139.
[67]张英.苦参提取物对人乳腺癌MCF-7细胞系肿瘤干细胞样细胞生物学行为的干预研究[D].北京:中国中医科学院,2009.
[68]Witt O,Deubzer H E,Milde T,et al.HDAC family:What are the cancer relevant targets?[J].Cancer Lett,2009,277:8.
[69]刘裕婷.新型去乙酰化酶抑制剂厚朴酚激活TRAIL通路诱导NSCLC凋亡的机制研究[D].广州:南方医科大学,2016.
[70]黎欢.艾可清2号组方及其他中药来源单体HDAC抑制活性研究[D].广州:广州中医药大学,2017.
[71]Yoon S,Eom G H.HDAC and HDAC inhibitor:from cancer to cardiovascular diseases[J].Chonnam Med J,2016,52:1.
[72]Battistuzzi G,Giannini G.Synthesis of ST7612AA1,a novel oral HDAC inhibitor,via radical thioacetic acid addition[J].Curr Bioact Compd,2016,12:282.
[73]Gorska M,Popowska U,Sielicka-Dudzin A,et al.Geldanamycin and its derivatives as Hsp90 inhibitors[J].Front Biosci,2012,1(17):2269.
[74]Wang J,Li Z,Lin Z,et al.17-DMCHAG,a new geldanamycin derivative,inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation[J].Cancer Lett,2015,362(1):83.
[75]Palermo C M,Westlake C A,Gasiewicz T A,et al.Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 k D heat shock protein[J].Biochemistry,2005,44:5041.
[76]Willem H K,Patricia L B,Chi V D.Otto Warburg's contributions tocurrent concepts of cancer metabolism[J].Nat Rev Cancer,2011,11:325.
[77]Li S,Li J,Dai W,et al.Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death[J].Br J Cancer,2017,117(10):1518.
[78]Hattori H,Okuda K,Murase T,et al.Isolation,identification and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis[J].Bioorg Med Chem,2011,19(18):5392.
[79]Ansell S M,Vonderheide R H.Cellular composition of the tumor microenvironment.American Society of Clinical Oncology educational book[J].Am Soc Clin Oncol Educ Book,2013,doi:10.1200/EdBook_AM.2013.33.e91.
[80]楼姣英,曹颖,金哲.中药对SiHa-CTL-Treg共培养体系中CTL细胞CTLA-4、PD-1蛋白的影响[J].北京中医药大学学报,2014,37(4):227.
[81]Vetizou M,Pitt J M,Daillere R,Lepage P,et al.Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota[J].Science,2015,350:1079.
[82]Stojanovic A,Cerwenka A.Naturalkiller cells and solid tumors[J].J Innate Immun,2011,3(4):355.
[83]宋浩然,白咸勇.红花组分抗肿瘤作用机制研究进展[J].中国民康医学,2016,28(24):43.
[84]林俊,李萍,陈靠山.近5年多糖抗肿瘤活性研究进展[J].中国中药杂志,2013,38(8):1116.
[85]Wang J M,Hu Y L,Wang D Y,et al.Sulfated modification can enhance the immune-enhancing activity of lycium barbarum polysaccharide[J].Cell Immunol,2010,263(2):219.
[86]李子豪,柯仲成,封亮,等.宝藿苷Ⅰ的制备方法及药理作用研究进展[J].中国中药杂志,2018,43(17):3444.
[87]Finnberg N,Klein-Szanto A J,El-Deiry W S.TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis[J].J Clin Invest,2008,118(1):111.
[88]Chen Z,Sangwan V,Banerjee S,et al.Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway[J].Cancer Lett,2014,348:1.
[89]Yong-Sik K,Eun-Ae K,Kyu-Gun P,et al.Dioscin sensitizes cells to TRAIL-induced apoptosis through downregulationof c-FLIP and Bcl-2[J].Oncol Rep,2012,28:5.
[90]Kou Y,Koag M C,Cheun Y,et al.Application of hypoioditemediated aminyl radical cyclization to synthesis of solasodine acetate[J].Steroids,2012,77:1069.
[91]Dai X,Zhang J,Arfuso F,et al.Targeting TNF-related apoptosis-inducing ligand(TRAIL)receptor by natural products as a potential therapeutic approach for cancer therapy[J].Exp Biol Med,2015,240(6):760.
[92]闫忠辉,李小平,刘煜.海洋植物来源的天然产物的研究进展[J].药物生物技术,2017,24(3):269.
[93]Brown A P,Morrissey R L,Faircloth G T,et al.Preclinical toxicity studies of kahalalide F,a new anticancer agent:single and muitiple dosing regiments in the rat[J].Canc Chem Pharmacol,2002,50(4):333.
[94]Linington R G,Edwards D J,Shuman C F,et al.Symplocamide A,a potent cytotoxin and chymotrypsin inhibitor from the marine cyanobacterium Symploca sp[J].J Nat Prod,2008,71:22.
[95]Kou Y,Lee S.Unexpected opening of steroidal E-ring during hypoiodite-mediated oxidation[J].Tetrahedron Lett,2013,54:4106.
[96]Cheun Y,Koag M C,Kou Y,et al.Transetherification-mediated E-ring opening and stereoselective"Red-Ox"modification of furostan[J].Steroids,2012,77:276.
[97]Koag M C,Cheun Y,Kou Y,et al.Synthesis and structure of16,22-diketocholesterol bound to oxysterol-binding protein Osh4[J].Steroids,2013,78:938.
[98]Perni M,Galvagnion C,Maltsev A,et al.A natural product inhibits the initiation ofα-synuclein aggregation and suppresses its toxicity[J].Proc Natl Acad Sci USA,2017,114:E1009.
[99]Wroblewski J J,Hu A Y.Topical squalamine 0.2%and intravitreal ranibizumab 0.5 mg as combination therapy for macular edema due to branch and central retinal vein occlusion:an open-label,randomized study[J].Ophthalmic Surg Lasers Imaging Retina,2016,47:914.
[100]Siegel R L,Miller K D,Jemal A.Cancer statistics,2018[J].CACancer J Clin,2018,68(1):7.
[101]Allemani C,Matsuda T,Di Carlo V,et al.Global surveillance of trends in cancer survival 2000-14(CONCORD-3):analysis of individual records for 37 513 025 patients diagnosed with one of18 cancers from 322 populationbased registries in 71 countries[J].Lancet,2018,391:1023.